SVT / AVNRT
- Most common ablation indication
- ~95% cure rate — 1 procedure
- Not life-threatening
- 1-2h procedure, same-day discharge
- No blood thinners needed after
Electrophysiology (EP) Study and Catheter Ablation — Mapping Your Heart's Electrical System and Correcting Abnormal Rhythms
Point your phone camera at the QR code, or visit
go.riasalimd.com/ep-ablation-guide
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| EP study (electrophysiology study) | A test done inside the heart. Thin wires go through groin veins to find where an abnormal rhythm starts. |
| Catheter ablation | Energy is sent through a thin tube to destroy the small area causing the abnormal rhythm. Energy types: heat (RF), cold (cryo), or electrical pulses (PFA). |
| Radiofrequency ablation (RFA) | The most widely used type. It heats tissue to create a scar. The scar blocks the abnormal electrical path. |
| Cryoablation (cryo / cryoballoon) | Freezes tissue to create a scar. A balloon catheter is often used for atrial fibrillation (AF) ablation. |
| Pulsed field ablation (PFA) | The newest type. Short electrical pulses destroy heart muscle cells. It spares nearby structures like the food pipe and breathing nerve. Farapulse and PulseSelect are FDA-approved PFA devices. |
| Pulmonary vein isolation (PVI) | The main goal of AF ablation. Scar tissue rings the four lung veins to stop AF triggers from spreading. |
| Electroanatomic mapping (EAM) | A 3D computer map of the heart's electrical activity. CARTO and EnSite are the two main mapping systems used in the lab. |
| Cavotricuspid isthmus (CTI) ablation | One line of ablation in the right atrium. This is the standard fix for atrial flutter. It works in 90-95% of cases. |
| AV-node ablation | Blocks the electrical junction between upper and lower heart chambers. Used only for hard-to-treat AF with fast rates. Requires a pacemaker. |
Which Arrhythmia Are You Having? Four Common Scenarios
Knowing your personal risks helps your care team take extra precautions.
| Risk Factor | Why It Increases Risk |
|---|---|
| AF for a long time | Scar builds up in the atrium over time. More scar means less chance of staying in normal rhythm after ablation. |
| Enlarged left atrium | A bigger left atrium has more changed tissue. This lowers success rates and raises AF return risk. |
| Weak heart or valve disease | Underlying heart problems create a harder electrical substrate. Ablation can still help but may need repeating. |
| Age and obesity | Both link to more atrial scar tissue. Results are a bit lower but ablation is still the best option. |
| Untreated sleep apnea | Sleep apnea stretches and stresses the atrium all night. Untreated, it nearly doubles the chance AF comes back. |
| Several failed heart rhythm drugs | Failing multiple drugs often means the rhythm problem is complex. But drug failure is also a main reason to refer for ablation. |
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| EP study + ablation (RF or cryo) | Bruising at groin: 2-4%. Heart tamponade (fluid around heart): ~1%. Stroke/TIA: <1% with blood thinners continued. Phrenic nerve injury with cryo: ~2-3% (usually goes away). Food-pipe injury (very rare, <0.1%) mainly with RF. PFA greatly lowers food-pipe risk. Low radiation exposure. | The only treatment that can cure the abnormal rhythm source. AVNRT/AVRT: ~95% success. Flutter: ~90-95%. AF: 70-80% paroxysmal, 50-60% persistent (1st ablation). CASTLE-AF: cut mortality 38% in AF + weak heart. PFA (Farapulse) matches RF results with better safety. | Heart rhythm drugs (flecainide, amiodarone, sotalol, dofetilide) — taken daily, require monitoring. Rate-control drugs. Cardioversion (shock to reset rhythm). AV-node ablation + pacemaker (last resort). |
| Pulsed field ablation — PFA (Farapulse, PulseSelect) | Same groin risks. Phrenic nerve injury: ~1-2% (lower than cryo). Food-pipe injury: nearly zero (ADVENT trial: 0 cases vs 2.4% with RF/cryo). Longer-term data still being collected. | Destroys heart muscle cells but spares the food pipe and breathing nerve. AF success equal to RF (ADVENT, NEJM 2023). Shorter procedure time (~90 vs ~150 min). Good choice for patients at higher risk for thermal side effects. | Standard RF or cryo ablation. Heart rhythm drugs. Observation. |
| Heart rhythm drugs vs ablation for AF | Each drug has side effects. Amiodarone: thyroid, lung, liver. Flecainide/propafenone: avoid with heart disease. Sotalol/dofetilide: must be started in hospital. All need blood tests and monitoring. | No procedure. Can be stopped if needed. Good for patients who want to delay ablation. CABANA trial: drugs vs ablation — ablation cut AF return and improved quality of life. | Catheter ablation. Rate-control drugs only. Close follow-up. |
| Rate control only — no rhythm control | AF continues over time, which can cause atrial scar. Less helpful in patients with a weak heart (CASTLE-AF). Risk of silent AF stroke remains. | No procedures needed. Low risk approach. Works for older or less symptomatic patients. AFFIRM trial: death rates similar to rhythm control for some patients. | Rhythm control (ablation or drugs). More frequent check-ins. |
Ablation by Arrhythmia — Approach, Success Rate, and Key Trial
| Arrhythmia | Target / Technique | Success (1st ablation) | Key Trial or Guideline |
|---|---|---|---|
| AVNRT (common SVT) | Slow-pathway modification, right atrium | ~95% | ACC/AHA/HRS SVT guideline 2015/2019 |
| AVRT / WPW | Extra pathway ablation (location varies) | ~93% | ACC/AHA/HRS SVT guideline 2015/2019 |
| Atrial flutter | CTI line ablation in right atrium | ~90-95% | HRS/EHRA/ECAS consensus |
| AF — paroxysmal | Pulmonary vein isolation (PVI) | 70-80% | CABANA 2019; STOP-AF 2021 |
| AF — persistent | PVI + extra lines | 50-60% | CABANA; EAST-AFNET 4 2020 |
| AF + weak heart | PVI + adjunctive ablation | ~50-60%; 38% mortality cut | CASTLE-AF 2018 (NEJM) |
| Frequent PVCs | Focal PVC ablation at origin site | ~80% | HRS/ACC registry; guideline Class I |
| Myth | Reality |
|---|---|
| Ablation is open-heart surgery. | It is not. There is no chest cut and no bypass machine. Small punctures in the groin are the only entry points. Most patients go home the same day. |
| One ablation cures AF in everyone. | SVT and atrial flutter are often cured in one session (about 95%). AF is different. One ablation frees about 70-80% of paroxysmal AF patients from AF at one year. Some need a second ablation. That is planned, not a failure. |
| I should stop blood thinners before ablation to prevent bleeding. | The opposite is true. Keeping blood thinners going lowers stroke risk. A clot during ablation is far more dangerous than a small extra bleed risk. Never stop blood thinners without your doctor's go-ahead. |
| Palpitations in the first month mean ablation failed. | The first 3 months are the blanking period. The scar is still forming. Early rhythm episodes during this time do NOT predict long-term failure. Doctors do not count these early episodes. |
| Pulsed field ablation (PFA) is experimental. | PFA (Farapulse, PulseSelect) is FDA approved and studied in large trials including ADVENT (NEJM 2023). It is fully approved — not investigational. It uses electrical pulses, not heat or cold, with a better safety record. |
| Once ablation works, I can stop my blood thinner. | Blood thinner decisions are based on your stroke risk score, not ablation results. Many patients need blood thinners long-term because AF can occur without symptoms. Ask your doctor — this decision is made case by case. |
| EP study is only for dangerous rhythms. | Many patients get ablation for SVT, which is rapid but not life-threatening. SVT can cause racing heart and dizziness that hurt daily life. Ablation is often the best long-term fix for SVT. |
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Bruising or hematoma at the groin | The most common issue — in 2-4% of patients. Large blood pockets are rare (<1%) but may need treatment. The doctor presses the groin for 15-20 minutes after the procedure. |
| Cardiac tamponade | Fluid around the heart if a catheter nicks the heart wall (~1%). Usually drained with a needle in the lab. Emergency surgery is rare. The team watches with an ultrasound the whole time. |
| Stroke or TIA | A clot can form and travel to the brain (<1%). Keeping blood thinners going and using heparin during the procedure cuts this risk. Mapping systems and careful technique lower risk further. |
| Phrenic nerve injury (with cryo) | The breathing nerve runs near the right-side lung veins. Cryo can affect it in ~2-3% of cases. Most cases go away on their own. PFA and RF have lower rates. |
| Lung vein narrowing | Scar tissue can narrow the lung veins after ablation. This is now rare (<1%) because ablation is done outside the vein opening. PFA cuts this risk even further. |
| Food-pipe fistula (very rare) | A rare but serious opening between the left atrium and the food pipe after RF ablation (less than 1 in 1,000). Symptoms: fever, stroke signs, 2-4 weeks after the procedure. PFA nearly removes this risk because it does not use heat. |
| Radiation exposure | X-ray is used during the procedure. Labs use low-dose settings. 3D mapping cuts x-ray time. The dose is tracked and kept as low as possible. |
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
Independent, evidence-based pages we recommend for deeper reading.
Automatic translation — not reviewed by a qualified medical translator and it may contain errors. The English version is the official one. For your medicines, symptoms, or an emergency, use the English or Spanish guide or call the office. In an emergency, call 911.
Automatic translation — not reviewed by a qualified medical translator and it may contain errors. The English version is the official one. For your medicines, symptoms, or an emergency, use the English or Spanish guide or call the office. In an emergency, call 911.
For anything about your medicines, symptoms, or an emergency, please use the English or Spanish guide, or call the office at (727) 943-5200. In an emergency, call 911.
Automatic translation is unavailable right now — showing the English version.
Go to English guide